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Summary  
Data for the prevalence of brucellosis in ruminants in Egypt are scarce; recent studies suggest 
the disease is endemic, with a high prevalence. The aim of this study was to assess the 
financial costs and the impact of the current control programme on the pattern of brucellosis 
among ruminants between 1999 and 2011. A univariate binary logistic regression model was 
used to compare between seropositive proportions for different years for each species. The 
proportion of seropositive cattle was significantly increased from 2000 to 2004 then 
significantly decreased from 2005 to 2011. The proportion of seropositive buffalo fluctuated 
year to year, however there was a significant increase in 2008 (OR 3.13, 95% CI 2.69-3.66, 
p< 0.001). There was a decrease in the proportion of seropositive sheep during the study 
period except in 2001 and 2009 in which there was a significant increase. The proportion of 
seropositive goats increased in 2000 and 2001, and then decreased from 2002 to 2007. In 
2008 there was a significant increase in the seropositive proportion of goats (OR 2.53, 95% 
CI 2.21-2.90, p<0.001). The average annual cost for the control programme including testing 
and compensation was more than US$3 million. The total cost for the control programme 
including testing and compensation for the period (13 years) between 1999 and 2011 was 
more than US$40 million, from which more than 56% for cattle. Further studies are required 
for the effectiveness of the current control strategies and alternative strategies should be 
considered. The socio-economic impact of brucellosis and its control measures should be 
investigated.  
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Introduction 
Brucellosis is a highly contagious disease affecting almost all domestic species, leading to 
severe economic losses due to abortion, infertility and reduced milk production. It is 
considered one of the most economically important zoonoses globally (Perry and Grace, 
2009; WHO 2009). The disease is not only endemic and neglected with high burdens in 
animals and human in low-income countries but also without effective control (McDermott 
and Arimi, 2002). Although the burden of brucellosis is greatest in developing countries, 
most data and evidence on the economic burden of brucellosis and the benefits of its control 
are from developed countries (McDermott et al., 2013). In Egypt, brucellosis was first 
reported in 1939 and, although data for the prevalence of brucellosis in ruminants are scarce, 
recent studies suggest the disease is endemic in all ruminant species. In Monufia 
Governorate, 5.36%, 3.33% and 3.17% of cattle, buffaloes and goats were seropositive for 
Brucella spp. by Rivanol test and 7.14%, 4.26%, 2.47% and 6.35% of cattle, buffaloes, sheep 
and goats were seropositive by the Buffered Acidified Plate Antigen (BAPA), respectively 
(Samaha et al., 2008). In another study, in which samples were collected from 126 herds from 
all over Egypt, 26.66%, 18.88% and 17.22% of sheep flocks, goat flocks and cattle herds 
were seropositive for Brucella spp. respectively (Kaoud et al., 2010). In Kafrelsheikh 
Governorate, blood samples from sheep and goats and milk samples from cattle and buffalo 
were tested for Brucella spp, the seroprevalence in cattle, buffaloes, sheep and goats was 
12.2%, 12%, 12.2% and 11.3%, respectively (Hegazy et al., 2011). In one of the Nile Delta 
villages, Monufia Governorate, the individual and household seroprevalence of Brucella spp. 
in cattle and buffaloes was 11.0% (95% CI: 3.06%-18.4%) and 15.5% (95% CI: 6.61%-
24.7%), respectively (Holt et al., 2011). More recently, the seroprevalence of Brucella was 
18.09% in blood samples from sheep and goat flocks from five governorates in the Nile Delta 
(Mahboub et al., 2013).    
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Brucellosis not only affects animals but humans can be infected via many potential routes 
such as consumption of raw milk and non-heat treated dairy products from infected animals 
or via contact with infected animals or contaminated materials from infected animals 
(Jennings et al., 2007; Glynn and Lynn, 2008). Although the disease in humans is rarely fatal, 
it can be severely debilitating and requires a long period of treatment. In addition to the cost 
of treatment, the inability to work increases economic losses caused by the disease (Pappas 
and Memish, 2007). In Egypt, data for prevalence or incidence of human brucellosis are 
scarce and almost all studies are based on hospital surveys. A study conducted in 2007 found 
that  3% and 11% of patient with acute febrile illness were positive for Brucella spp. by 
culture and serology, respectively (Afifi et al., 2007). In 2000, the incidence was estimated to 
be 18/100,000 person-year in Bilbeis district (Crump et al., 2003). In Fayoum governorate, it 
was estimated to be 64/100,000 person-year and 70/100,000 person-year in 2002 and 2003, 
respectively (Jennings et al., 2007); However, data from the Ministry of Health provide an 
incidence of 0.3/100,000 person-year (Pappas et al., 2006). The incidence rate in 2007, 2008 
and 2009 was 6.4, 6.61 and 4.62/100,000 person-year, respectively. However these figures 
are not reliable because hospitals are required to notify the cases of brucellosis to the 
Ministry of Health. In practice notifications only come from governmental hospitals but not 
from private health centres, private clinics and private hospitals, so the incidence in human 
populations is likely to be underestimated.    
Since 1981, the national  programme for brucellosis in ruminants in Egypt involves testing all 
female ruminants older than six months and slaughtering serological positives, with voluntary 
vaccination of calves using Brucella abortus S19 vaccine and lambs and kids using B. 
melitensis Rev.1 vaccine (Refai, 2002). According to the General Organization of Veterinary 
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Services (GOVS), in 2012, 360,000 animals were tested costing about one million US$
1
 and 
50,000 cattle and 50,000 sheep were vaccinated, costing about US$ 90,000 for the vaccine. 
However the previous findings in both ruminants and human indicate that the disease is 
endemic in the country and affecting both animals and humans. There has been no economic 
evaluation conducted for the current programme of brucellosis in Egypt. The aim of this 
study was to assess the financial costs and the impact of the current programme on the 
temporal pattern of brucellosis among cattle, buffalo, sheep and goats using data from the 
active surveillance programme between 1999 and 2011.  
Materials and methods 
Study area and ruminant population 
Egypt is located in the north-eastern corner of Africa and south-western Asia (27,00º N, 
30,00º E). It is bounded on the north by the Mediterranean Sea, on the east by Palestine, on 
the south by Sudan, and on the west by Libya. The total area is about one million square 
meters and composed of 27 administrative governorates, while the populated area is about 
78990 km
2
 (7.8% of the total area). The human population according to the most recent 
survey is about 94 million, both at home and abroad
2
. In Egypt, the majority of cattle are 
owned by individual households, and kept in groups of one to five and moved daily between 
the house yard and grazing lands. Sheep and goat are also kept in small flocks that are often 
composed of animals from various households managed by a single shepherd. Some larger 
mobile flocks are also kept, and there are a small number of government and privately-owned 
commercial dairy farms (Aidaros 2005; Holt et al., 2011). The Nile Delta, is the most densely 
populated area, while upper Egypt, and especially the desert regions, are less populated. 
Livestock demographic data (Figure 1) and the number of animals tested for brucellosis, 
                                                          
1
 Current exchange rate; 1 US$=6.06 LE (Egyptian pound) according to the world bank exchange rate for 2012 
http://data.worldbank.org/indicator/PA.NUS.FCRF  
2
 http://www.sis.gov.eg/En/Default.aspx 
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together with the results of the tests for each species, were obtained from the GOVS and are 
reported by Wareth et al. (2014).  
Description of the national brucellosis control programme 
Data on the numbers of animals tested for brucellosis were provided by the GOVS based on 
the active surveillance programme for brucellosis. Within this programme, the GOVS’ 
veterinarians collect blood samples from all female ruminants nationally. Serum samples are 
serologically tested for Brucella spp. antibodies using Rose Bengal Plate Test (RBPT), 
positive samples are then confirmed by the Complement Fixation Test (CFT) at the 
Department of Brucellosis Research, Animal Health Research Institute (AHRI) according to 
the OIE guidelines. Brucellosis confirmed cases are slaughtered under the supervision of 
GOVS’ veterinarians at the government abattoirs and owners are compensated according to 
the compensation scheme (Refai, 2002).  
Costs of brucellosis control programme 
Surveillance and testing of animals 
According to the programme, GOVS’ veterinarians are responsible for collecting blood 
samples from animals all over the country. The Egyptian Ministry of Agriculture is 
responsible for logistics and for supplying all material needed such as vehicles, needles, 
blood tubes, and ice boxes. The cost of sampling an individual animal is US$ 1.93 for labour, 
and US$ 1 for consumables (needles, tubes, syringes and ear tags) and administration 
(planning, implementing and transporting samples from sites of collection to the laboratory). 
The cost of the serological tests, RBPT and CFT, is US$ 1.93 each, including reagents, 
consumables and labour. The previous costs were based on the actual prices and expert 
opinions. 
Compensation for animals slaughtered 
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According to the programme, the slaughter of seropositive animals by both RBPT and CFT 
under the supervision of GOVS is compulsory and livestock owners compensated. The 
amount of compensation varied according to the species, age and breed of seropositive 
animals, Table 1. As there were no detailed data for the species, breed and age of 
compensated cattle and buffalo an average of US$ 747 was used to calculate the 
compensation of a cattle or buffalo.   
Vaccination  
Vaccination against brucellosis is voluntary. The cost of a single dose of vaccine is about one 
US$ which is administered by a GOVS’ veterinarian. The cost of transporting, cold chain, 
syringes, needles, ear tags and labour for a single animal is one US$ (Expert opinion). By 
law, animals must be tested before being vaccinated; therefore the cost of sampling and 
testing (as detailed before) was added to the cost of vaccination. Accurate figures for the total 
number or the proportion of animals vaccinated annually were not available. Based on 
personal communication with veterinarians from GOVS, it seems that about 100,000 animals 
are vaccinated every year.   
Data management and analysis 
Data were stored in a Microsoft Office Excel 2007. Frequency tables were used to calculate 
the proportions of animals tested and proportions seropositive for Brucella spp. per year for 
each ruminant species. Statistical analyses were conducted to allow comparison between 
different years and ruminant species using IBM SPSS Statistics for Windows, Version 20.0. 
Armonk, NY: IBM Corp. Univariable logistic regression was used to compare the proportion 
of seropositive animals in each species for different years, with seropositive as the response 
variable and 1999 as the reference year.  
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Results 
A total number of 4,331,154 animals were tested between 1999 and 2011. The results (Figure 
2) showed that, the frequency of testing cattle was higher than other species with a maximum 
of 4.34% in 2006. The proportion of tested buffalo and sheep was below 2% except in 2001 
(2.3% in buffalo). The proportion of tested goat was less than 1% apart from 2008 and 2009 
in which 1.04% and 1.06% were tested, respectively. The results of serological tests (Figure 
3) showed that, the highest proportion of seropositive was in sheep, followed by goat, cattle 
and buffalo with an average of 1.68%, 1.18%, 0.73% and 0.48%, respectively.  
The highest proportions of seropositive cattle (1.27%), buffalo (1.08%), sheep (3.65%) and 
goat (3.22%) were observed in 2002, 2008, 2009 and 2008, respectively. The proportion of 
seropositive cattle was significantly increased from 2000 to 2004 then significantly decreased 
from 2005 to 2011, Table 2. The proportion of seropositive buffalo fluctuated year to year, 
however there was a significant increase in 2008 (OR 3.13, 95% CI 2.69-3.66, p< 0.001), 
Table 3. There was a decrease in the proportion of tested sheep that were seropositive during 
the study period except in 2001 and 2009 in which there was a significant increase, Table 4. 
The proportion of seropositive goats increased in 2000 and 2001, and then decreased from 
2002 to 2007. In 2008 there was a significant increase in the seropositive proportion of goats 
(OR 2.53, 95% CI 2.21-2.90, p<0.001), Table 5. The seropositive proportion of ruminants 
showed a slight increase from 1999 to 2004 then decreased a part from 2008 and 2009 in 
which there was an increase, Table 6.   
The average annual cost for sampling and testing cattle was about US$ 800,000 followed by 
sheep, less than US$ 400,000 then buffalo and goat, Figure 4. The average annual cost for 
testing all ruminants was about US$ 1,658,000. The total costs for sampling and testing 
ruminants in the study period was US$ 21,554,630 with more than 50% for cattle. The 
average compensation for cattle, US$ 927,733, was higher than other species, Figure 5. The 
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average annual compensation cost for all ruminants was about US$ 1,428,000. The total 
compensation in the study period was US$ 18 million with cattle about 65%. The average 
annual total cost for the control programme including testing and compensation was more 
than US$ 3 million. The highest costs were for cattle particularly in year 2002 and 2003, 
Figure 6. The total cost for the control programme including testing and compensation in the 
study period was US$ 40,112,726, from which more than 56% for cattle. According to 
experts from GOVS, the annual cost for voluntary vaccination was about US$ 700,000. 
Discussion 
Since 1981, several control measures have been implemented with the aim to eradicate 
brucellosis however it is still endemic in the country. The official brucellosis disease control 
strategy stipulates that all female ruminants and valuable males aged ≥ 6 months are 
serologically tested for brucellosis every 6 months. The results indicated that in any given 
year between 1999 and 2011, the proportion of tested ruminants never exceeded 2.15%. This 
low proportion of testing could be due to many reasons such as lack of funds, shortage in 
laboratory facilities and trained staff (Refai, 2002). It was found that, livestock owners were 
unwilling to test their animals, fearing that positive ones will be culled with unsatisfactory 
compensation (Holt et al., 2011). Studies have also found farmers and veterinarians lack 
motivation, with insufficient funding to sustain the control programme (Hegazy et al., 2009). 
Our results showed that there were huge variations in the intensity of testing across species 
and from year to another, although the proportion of testing cattle was consistently higher 
than other species all over the study period. This is likely to affect the efficacy of the control 
programme and allow the persistence of the disease in the population. It suggests that a 
formal sampling strategy is not adhered to and consequently the paucity of reliable estimates 
for the disease in the country. It might also reflect that, policy makers wrongly believed that 
large cattle are the main source of brucellosis in Egypt. The high intensity of sampling cattle 
might also be due to the characteristics of the production system stated above and that it 
might be easy for GOVS’ veterinarians to collect samples from cattle compared to other 
species.  
The proportion of seropositive cattle and buffalo was quite low over the study period and 
rarely exceeded 1%. However, results from other regional or sub-regional studies indicated 
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that the seroprevalence of brucellosis in cattle and buffalo was ranged from about 3% to 17% 
(Samaha et al., 2008; Hegazy et al., 2011; Holt et al., 2011; Mahboub et al., 2013). The 
proportion of seropositive sheep was around 2% except in 2009 (3.7%), which is quite lower 
than findings by other regional studies (3% to 26%) (Samaha et al., 2008; Hegazy et al., 
2011; Holt et al., 2011; Mahboub et al., 2013). However, poor implementation of random 
sampling strategies increases the unreliability of the outcomes (Hegazy et al., 2009). To the 
authors’ knowledge, veterinarians always used convenient sampling rather than random 
sampling such as sampling households near veterinary clinics, near the main roads and those 
they have a business relationship with. Therefore these figures should be interpreted 
carefully, and it is not possible to extrapolate these results to the national livestock population 
in Egypt. There were no clear temporal variations in the proportion of seropositive animals in 
any species across the study period. Due to the small proportion of animals tested or 
vaccinated the programme, as currently implemented, is very unlikely to neither eradicate 
brucellosis nor control it effectively. 
For assessing the socioeconomic impact of brucellosis, data of the direct and indirect impact 
of the disease on animals and human are required eg; production data and the losses due to 
brucellosis in animals and the losses and costs of brucellosis in humans. Also valid animal 
disease incidence and loss data, both within infected herds and in the national population of 
herds, is extremely important for sound epidemiological and cost-benefit studies of animal 
disease programs. In Egypt, most of these data were lacking, further studies are required to 
conduct a socio-economic impact of brucellosis and a benefit-cost analysis for the control 
programme. However, it was possible to estimate the monetary costs for the control 
programme. About US$ 1,658,000 were spent annually for sampling and testing of all 
ruminants; of which more than 50% were spent on cattle. This money could be used more 
effectively by using a strategic sampling frame with epidemiologically sound study design. 
As a part of the programme, serologically positive animals are slaughtered and owners are 
compensated. About US$ 1,428,000 were spent as compensation per year with about 65% for 
cattle. However, it is unlikely that farmers would be satisfied with the level of compensation 
as it represents less than 50% of the market value. This could be one of the main factors 
hindering the success of the control programme (Hegazy et al., 2009; Hegazy et al., 2011; 
Holt et al., 2011). Farmers may be more willing to comply with serological testing 
requirements if compensation was given at the market value of the positive animals and the 
process of compensation was easier and faster than it is currently. The average cost for the 
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control programme including testing and compensation was more than US$ 3 million per 
year and the total cost in the study period was more than US$ 40 million. This amount of 
money, will only be justified if the disease is well led. With complete control of brucellosis, 
money would be used for the improvement of livestock production, food security and public 
health (Bamaiyi et al., 2012). Apparently, control of brucellosis seems expensive but it was 
estimated that for each US$1 expenditure on control, US$ 7 were saved (Acha and Szyfres, 
1987).  A simulation study of the effective  strategies for brucellosis in small ruminants in 
one of the Nile Delta Governorates indicated that vaccination of 50% of young replacements 
and 25% of adult sheep every year would reduce the seroprevalence of brucellosis by 75% 
after 10 years (Hegazy et al., 2009). In Mongolia, it has been estimated that the annual mass 
vaccination of livestock against brucellosis for 10 years would reduce the prevalence of 
brucellosis by 52% (Zinsstag et al., 2005; Zinsstag et al., 2007). Therefore, an economic 
analysis would be required to determine whether these technically more effective strategies 
would be more cost-effective as well. 
Despite more than 30 years of implementation of control and compensation scheme for 
brucellosis with voluntary vaccination, brucellosis is still endemic in Egypt. To develop a 
national strategy for control or eradication of brucellosis, the veterinary authorities should 
select an approach compatible with the prevailing socioeconomic status and the prevalence of 
the disease. As part of the strategy, the impact of brucellosis on the livestock economy and 
human health and the costs of the potential control or eradication strategies must be evaluated 
before implementation. Knowledge and attitudes of different stakeholders, which may vary 
between different regions of the country, and the availability of resources to carry out the 
strategy should also be considered (Blasco and Molina-Flores, 2011).  
In designing an effective policy for controlling brucellosis the following critical factors 
should be considered, the prevalence of infection, species of Brucella prevalent, animal 
species involved and the temporal pattern of the prevalence or incidence in animals and 
humans (Robinson, 2003). To achieve that, well designed studies for collecting data about, 
risk factors, prevalence and economic impact of the disease and its control measures should 
be conducted. Alternative or complementary control strategies could include vaccination of 
small and large ruminants, biosecurity measures and movement control (Blasco and Molina-
Flores, 2011). Any control programme must be accompanied by strong surveillance systems 
to monitor the progress of the programme and detect any new infections in both people and 
livestock herds or flocks. Simulation studies for assessing the efficacy of different control 
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strategies should be carried out. The simulation study previously conducted in Egypt (Hegazy 
et al., 2009) was for small ruminants only, it has not simulated the disease in large ruminants 
and other production characteristics. To our knowledge, there were no simulation studies for 
the economic impacts of the disease and its control measures in Egypt. This type of studies is 
very important especially when there are no enough resources to frequently test large number 
of animals to evaluate the actual status of the disease in the population. So, simulations could 
predict the situation of the disease in the population and the outcomes could be confirmed 
with a small sample every year. Also simulation studies would be helpful for assessing the 
efficacy of alternative disease control strategies and their economic impacts. Outcomes of 
these studies would help policymakers applying the appropriate control programme and 
efficient allocation of resources.   
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Tables 
Table 1: Compensation for animals slaughtered by brucellosis control programme in Egypt (source: GOVS) 
Species/breeds Age Compensation/US$ 
Cattle and buffalo  < 6 months 325 
Foreign breeds cattle, buffalo 
and bulls  
From 6 months to 2 years 616 
From 2 to 5 years 1387 
>5 years 971 
Mixed breeds From 6 months to 2 years 462 
From 2 to 5 years 1156 
>5 years 701 
Baladi cattle and buffalo 
(native breeds) 
From 6 months to 2 years 385 
From 2 to 5 years 925 
>5 years 539 
Sheep All ages 162 
Goat All ages 115 
     
Table 2: Proportions of seropositive cattle for Brucella spp. Based on the brucellosis control programme in Egypt, 1999-
2011 
Year Tested  Seropositive Seropositive (%) OR 95% CI P value 
1999 108,622 824 0.76 Ref. - - 
2000 145,750 1,305 0.90 1.18 1.08-1.29 <0.001 
2001 152,436 1,378 0.90 1.19 1.09-1.29 <0.001 
2002 162,309 2,067 1.27 1.68 1.55-1.82 <0.001 
2003 168,281 2,009 1.19 1.57 1.45-1.71 <0.001 
2004 154,984 1,406 0.91 1.19 1.09-1.30 <0.001 
2005 174,673 1,291 0.74 0.97 0.89-1.06 0.56 
2006 199,954 982 0.49 0.65 0.59-0.71 <0.001 
2007 161,206 843 0.52 0.69 0.63-0.76 <0.001 
2008 182,248 1,186 0.65 0.86 0.78-0.93 <0.001 
2009 175,750 871 0.50 0.65 0.59-0.72 <0.001 
2010 183,490 640 0.35 0.46 0.41-0.51 <0.001 
2011 167,188 592 0.35 0.47 0.42-0.52 <0.001 
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Table 3: Proportions of seropositive buffalo for Brucella spp. Based on the brucellosis control programme in Egypt, 1999-
2011 
Year Tested  Seropositive Seropositive (%) OR 95% CI P value 
1999 62,900 218 0.35 Ref. - - 
2000 66,109 391 0.59 1.71 1.45-2.02 <0.001 
2001 81,302 288 0.35 1.02 0.86-1.22 0.80 
2002 67,802 331 0.49 1.41 1.19-1.67 <0.001 
2003 67,588 471 0.70 2.02 1.72-2.37 <0.001 
2004 56,041 373 0.67 1.93 1.63-2.28 <0.001 
2005 69,931 266 0.38 1.10 0.92-1.31 0.30 
2006 61,595 165 0.27 0.77 0.63-0.95 0.012 
2007 68,548 334 0.49 1.41 1.19-1.67 <0.001 
2008 59,080 637 1.08 3.13 2.69-3.66 <0.001 
2009 51,924 196 0.38 1.09 0.89-1.32 0.384 
2010 53,783 162 0.30 0.87 0.71-1.06 0.17 
2011 55,986 112 0.20 0.58 0.46-0.72 <0.001 
 
Table 4: Proportions of seropositive sheep for Brucella spp. Based on the brucellosis control programme in Egypt, 1999-
2011 
Year Tested  Seropositive Seropositive (%) OR 95% CI P value 
1999 62,151 1,437 2.31 Ref. - - 
2000 68,342 1,303 1.91 0.82 0.76-0.89 <0.001 
2001 78,310 1,967 2.51 1.09 1.02-1.17 0.01 
2002 99,466 1,111 1.12 0.48 0.44-0.52 0.0001 
2003 79,565 1,755 2.21 0.95 0.89-1.02 0.18 
2004 68,122 1,081 1.59 0.68 0.63-0.74 <0.001 
2005 69,571 1,203 1.73 0.74 0.69-0.80 <0.001 
2006 71,929 905 1.26 0.54 0.50-0.59 <0.001 
2007 68,171 924 1.36 0.58 0.53-0.63 <0.001 
2008 106,215 968 0.91 0.39 0.36-0.42 <0.001 
2009 84,798 3,095 3.65 1.60 1.50-1.71 <0.001 
2010 66,412 525 0.79 0.34 0.30-0.37 <0.001 
2011 65,849 292 0.44 0.19 0.17-0.21 <0.001 
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Table 5: Proportions of seropositive goat for Brucella spp. Based on the brucellosis control programme in Egypt, 1999-
2011 
Year Tested  Seropositive Seropositive (%) OR 95% CI P value 
1999 17,875 232 1.30 Ref. - - 
2000 16,685 294 1.76 1.36 1.15-1.62 <0.001 
2001 21,912 331 1.51 1,17 0.99-1.38 0.07 
2002 23,560 307 1.30 1.00 0.85-1.19 0.96 
2003 29,576 314 1.06 0.85 0.69-0.97 0.01 
2004 25,719 329 1.28 0.99 0.83-1.17 0.86 
2005 25,325 257 1.01 0.78 0.65-0.93 0.006 
2006 26,689 237 0.89 0.68 0.57-0.82 <0.001 
2007 33,791 163 0.48 0.37 0.30-0.45 <0.001 
2008 46,703 1,502 3.22 2.53 2.21-2.90 <0.001 
2009 44,023 322 0.73 0.56 0.47-0.66 <0.001 
2010 39,143 233 0.60 0.46 0.38-0.55 <0.001 
2011 31,772 83 0.26 0.21 0.15-0.26 <0.001 
 
17 
 
Table 6: Proportions of seropositive ruminants for Brucella spp. Based on the brucellosis control programme in Egypt, 
1999-2011 
Year Tested  Seropositive Seropositive (%) OR 95% CI P value 
1999 251,548 2,711 1.08 Ref - - 
2000 296,886 3,293 1.11 1.03 0.98-1.08 0.264 
2001 333,960 3,964 1.19 1.10 1.05-1.16 <0.001 
2002 353,137 3,816 1.08 1.00 0.95-1.05 0.92 
2003 345,010 4,549 1.32 1.23 1.17-1.29 <0.001 
2004 304,866 3,189 1.05 0.97 0.92-1.02 0.25 
2005 339,500 3,017 0.89 0.82 0.78-0.87 <0.001 
2006 360,167 2,289 0.64 0.59 0.56-0.62 <0.001 
2007 331,716 2,264 0.68 0.63 0.59-0.67 <0.001 
2008 394,246 4,293 1.09 1.01 0.96-1.06 0.672 
2009 356,495 4,484 1.26 1.17 1.11-1.23 <0.001 
2010 342,828 1,560 0.46 0.42 0.39-0.45 <0.001 
2011 320,795 1,079 0.34 0.31 0.29-0.33 <0.001 
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Figures 
 
Figure 1: Number of cattle, buffalo, sheep and goat per/year in Egypt from 1999 to 2011 
 
Figure 2: Proportions of serologically tested ruminants for brucellosis control programme in Egypt, 1999-2011 
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Figure 3: Proportions of seropositive ruminants for Brucella spp. based on the brucellosis control programme in Egypt, 
1999-2011 
 
Figure 4: The annual costs (USD) for sampling and testing for brucellosis control programme in Egypt, 1999-2011 
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Figure 5: The annual compensation (USD) for brucellosis control programme in Egypt, 1999-2011 
 
Figure 6: Total annual costs (USD) for the brucellosis control programme in Egypt 
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